SUCCESSFUL TREATMENT AND PROPHYLAXIS OF SCALP SEBORRHEIC DERMATITIS AND DANDRUFF WITH 2-PERCENT KETOCONAZOLE SHAMPOO - RESULTS OF A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引:68
|
作者
PETER, RU [1 ]
RICHARZBARTHAUER, U [1 ]
机构
[1] JANSSEN RES FDN,W-4040 NEUSS,GERMANY
关键词
D O I
10.1111/j.1365-2133.1995.tb08680.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Pityrosporum ovale appears to play an important role in the pathogenesis of seborrhoeic dermatitis. Ketoconazole is an antimycotic agent with a high in vitro and in vivo efficacy against P. ovale. We performed a multicentre study to investigate the efficacy of ketoconazole 2% shampoo in the treatment and prophylaxis of seborrhoeic dermatitis and dandruff. Five hundred and seventy-five patients presenting with moderate to severe seborrhoeic dermatitis and dandruff of the scalp were treated with 2% ketoconazole shampoo twice weekly for 2-4 weeks, producing an excellent response in 88%. Of those patients who responded, 312 were included in a prophylactic phase, lasting 6 months. These patients were treated with the active preparation (shampoo containing 2% ketoconazole) once-weekly, once every other week, alternating with placebo (shampoo without ketoconazole), or with placebo only once-weekly. Forty-eight (47%) patients in the placebo group experienced a relapse of seborrhoeic dermatitis compared with 23 (19%) patients in the active treatment group, and 31 (31%) patients in the active/placebo group. The medication was well tolerated in all three groups. We conclude that ketoconazole 2% shampoo is highly effective, not only in clearing scalp seborrhoeic dermatitis and dandruff, but also in preventing relapse of the disease when used prophylactically once weekly.
引用
收藏
页码:441 / 445
页数:5
相关论文
共 50 条
  • [21] A double-blind placebo-controlled trial of nabumetone in the prophylaxis of migraine
    Diamond, S
    Freitag, FG
    Diamond, ML
    Urban, GJ
    Pepper, BJ
    HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH, 1996, 7 (04): : 326 - 329
  • [22] A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF INDOBUFEN IN THE PROPHYLAXIS OF MIGRAINE
    CARRIERI, PB
    OREFICE, G
    SORGE, F
    ACTA NEUROLOGICA SCANDINAVICA, 1988, 77 (06): : 433 - 436
  • [23] Gabapentin in the treatment of fibromyalgia - A randomized, double-blind, placebo-controlled, multicenter trial
    Arnold, Lesley M.
    Goldenberg, Don L.
    Stanford, Sharon B.
    Lalonde, Justine K.
    Sandhu, H. S.
    Keck, Paul E., Jr.
    Welge, Jeffrey A.
    Bishop, Fred
    Stanford, Kevin E.
    Hess, Evelyn V.
    Hudson, James I.
    ARTHRITIS AND RHEUMATISM, 2007, 56 (04): : 1336 - 1344
  • [24] Polypodium leucotomos Extract in Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
    Ramirez-Bosca, A.
    Zapater, P.
    Betlloch, I.
    Albero, F.
    Martinez, A.
    Diaz-Alperi, J.
    Horga, J. F.
    ACTAS DERMO-SIFILIOGRAFICAS, 2012, 103 (07): : 599 - 607
  • [25] Multicenter randomized double-blind placebo-controlled trial of ibuprofen prophylaxis in very preterm infants
    Van Overmeire, B
    Casaer, A
    Allegaert, K
    Debauche, C
    Decaluwe, W
    Jespers, A
    Weyler, J
    Langhendries, JP
    PEDIATRIC RESEARCH, 2002, 51 (04) : 379A - 379A
  • [26] Heparan sulfate in the treatment of intermittent claudication: Results of a randomized, double-blind, placebo-controlled multicenter trial
    Messa, GL
    Gelso, E
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 2002, 28 (01) : 37 - 48
  • [27] SERLOPITANT FOR TREATMENT OF CHRONIC PRURITUS: RESULTS OF A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 CLINICAL TRIAL
    Yosipovitch, Gil
    Stander, Sonja
    Kerby, Matthew B.
    Larrick, James W.
    Perlman, Andrew J.
    Schnipper, Edward F.
    Zhang, Xiaoming
    Tang, Jean Y.
    Luger, Thomas A.
    Steinhoff, Martin
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 1015 - 1015
  • [28] Topiramate in the prophylaxis of pediatric migraine: A double-blind placebo-controlled trial
    Lakshmi, C. V. S.
    Singhi, Pratibha
    Malhi, Prahbhjot
    Ray, MLinni
    JOURNAL OF CHILD NEUROLOGY, 2007, 22 (07) : 829 - 835
  • [30] Milnacipran for the treatment of fibromyalgia syndrome: a european multicenter, double-blind, placebo-controlled trial
    Branco, J.
    Bragee, G.
    Zachrisson, O.
    Mikkelsen, K.
    De Teresa, L.
    Mainguy, Y.
    Galissie, M.
    Lugardon, S.
    Pezous, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S574 - S575